The global Spinal Muscular Atrophy Market is estimated to be valued at US$ 1,600.6 million in 2022 and is expected to exhibit a CAGR of 13.3% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Spinal Muscular Atrophy (SMA) is a rare genetic disorder characterized by the loss of motor neurons, leading to progressive muscle weakness and atrophy. The market for SMA treatment is witnessing ... Read more